Jerzy Gumulka - 10 Apr 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-Fact
Issuer symbol
CNSP
Transactions as of
10 Apr 2023
Net transactions value
+$5,308
Form type
4
Filing time
17 Apr 2023, 08:17:37 UTC
Previous filing
16 Jul 2021
Next filing
21 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $5,308 +7,173 $0.7400 7,173 10 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.